Exact Therapeutics (Norway) Management Evaluation
| EXTX Stock | NOK 3.80 0.02 0.53% |
Exact Therapeutics employs about 8 people. The company is managed by 10 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 0.8 employees per reported executive. Inspection of Exact Therapeutics' management performance can provide insight into the company performance.
| Per Walday Executive Chief Officer |
| Dominic Aca Executive Chief Officer |
Exact |
Exact Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.256) % which means that it has lost $0.256 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4619) %, meaning that it generated substantial loss on money invested by shareholders. Exact Therapeutics' management efficiency ratios could be used to measure how well Exact Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Exact Therapeutics Workforce Comparison
Exact Therapeutics AS is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 26,740. Exact Therapeutics adds roughly 8.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Exact Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Exact Therapeutics Price Series Summation is a cross summation of Exact Therapeutics price series and its benchmark/peer.
Exact Therapeutics Notable Stakeholders
An Exact Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Exact Therapeutics often face trade-offs trying to please all of them. Exact Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Exact Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Per Sontum | Founder | Profile | |
| Svein Kvle | Co COO | Profile | |
| Ragnar Bendicksen | VP Technology | Profile | |
| Per Walday | Chief Officer | Profile | |
| Dominic Aca | Chief Officer | Profile | |
| John Edminson | Chief Officer | Profile | |
| Amir MD | Chief Officer | Profile | |
| Hilary MD | Chief Officer | Profile | |
| Masha DPHIL | ViceChair Board | Profile | |
| Andrew Healey | Co Officer | Profile |
About Exact Therapeutics Management Performance
The success or failure of an entity such as Exact Therapeutics often depends on how effective the management is. Exact Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Exact management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Exact management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway.
Exact Therapeutics Workforce Analysis
Traditionally, organizations such as Exact Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Exact Therapeutics within its industry.Exact Therapeutics Manpower Efficiency
Return on Exact Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 7.3M | |
| Net Loss Per Executive | 5.9M |
Other Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.